# Aprea Therapeutics, Inc.: Form DEF 14A, filed Apr 25, 2024

- Company: [Aprea Therapeutics, Inc.](/companies/apre.md) (CIK 1781983)
- Form: DEF 14A
- Filed: 2024-04-25
- Accepted by EDGAR: Apr 25, 2024, 07:00 ET
- Period: 2024-06-20
- Accession: 0001558370-24-005678
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1781983/000155837024005678/apre-20240620xdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1781983/000155837024005678/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1781983/000155837024005678/apre-20240620xdef14a.htm

Filed Apr 25, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-005678. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.